FDA Inspection 878249 — Riaz Baber
The FDA completed an inspection of Riaz Baber on May 19, 2014 in Naperville, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- May 19, 2014
- Fiscal Year
- 2014
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Naperville, IL (United States)
Additional Details
Clinical Investigator (CI)